324 related articles for article (PubMed ID: 18565293)
1. [Biologics in skin diseases other than psoriasis].
Gniadecki R; Skov L
Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
[TBL] [Abstract][Full Text] [Related]
2. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).
Graves JE; Nunley K; Heffernan MP
J Am Acad Dermatol; 2007 Jan; 56(1):e55-79. PubMed ID: 17190618
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
Trent JT; Kerdel FA
Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies in dermatological practice].
Rudnicka L; Szymańska E; Oledzka E; Olszewska M
Pol Merkur Lekarski; 2005 Dec; 19(114):839-42. PubMed ID: 16521437
[TBL] [Abstract][Full Text] [Related]
5. Non-psoriatic dermatologic uses of monoclonal antibody therapy.
Sockolov ME; Alikhan A; Zargari O
J Dermatolog Treat; 2009; 20(6):319-27. PubMed ID: 19954387
[TBL] [Abstract][Full Text] [Related]
6. [Biological dermatologic agents. The Danish Society of Dermatology].
Iversen L; Kragballe K;
Ugeskr Laeger; 2007 Mar; 169(12):1100. PubMed ID: 17394811
[No Abstract] [Full Text] [Related]
7. Cytokine blocking agents in dermatology.
Williams JD; Griffiths CE
Clin Exp Dermatol; 2002 Oct; 27(7):585-90. PubMed ID: 12464154
[TBL] [Abstract][Full Text] [Related]
8. Experience with biologics for psoriasis in daily practice: switching is worth a try.
Lecluse LL; de Groot M; Bos JD; Spuls PI
Br J Dermatol; 2009 Oct; 161(4):948-51. PubMed ID: 19663876
[No Abstract] [Full Text] [Related]
9. Complications and adverse reactions in the use of newer biologic agents.
Callen JP
Semin Cutan Med Surg; 2007 Mar; 26(1):6-14. PubMed ID: 17349557
[TBL] [Abstract][Full Text] [Related]
10. [What's new in dermatological treatments?].
Martin L
Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S165-76. PubMed ID: 21193120
[TBL] [Abstract][Full Text] [Related]
11. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept.
Field S; Regan AO; Sheahan K; Collins P
Clin Exp Dermatol; 2010 Oct; 35(7):795-6. PubMed ID: 20831604
[No Abstract] [Full Text] [Related]
12. Biologic therapeutics in the treatment of psoriasis. Part 1: review.
Langley RG; Gupta AK; Cherman AM; Inniss KA
J Cutan Med Surg; 2007; 11(3):99-122. PubMed ID: 17511926
[TBL] [Abstract][Full Text] [Related]
13. [Biologics in the treatment of psoriasis].
Dissemond J; Grabbe S
MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
[TBL] [Abstract][Full Text] [Related]
14. Biologicals in the treatment of psoriasis.
Boker A; Kimball AB; Rolz-Cruz G
Curr Opin Investig Drugs; 2007 Nov; 8(11):939-46. PubMed ID: 17979028
[TBL] [Abstract][Full Text] [Related]
15. Rituximab: applications in dermatology.
Fatourechi MM; el-Azhary RA; Gibson LE
Int J Dermatol; 2006 Oct; 45(10):1143-55; quiz 1155. PubMed ID: 17040427
[TBL] [Abstract][Full Text] [Related]
16. [The role of biological drugs in the treatment of psoriasis, results from 9 randomized placebo-controlled trials].
Kemény L; Brodszky V; Kárpáti K; Gulácsi L
Orv Hetil; 2006 May; 147(21):981-90. PubMed ID: 16812973
[TBL] [Abstract][Full Text] [Related]
17. Biological agents in the treatment of psoriasis.
Tzu J; Krulig E; Cardenas V; Kerdel FA
G Ital Dermatol Venereol; 2008 Oct; 143(5):315-27. PubMed ID: 18833073
[TBL] [Abstract][Full Text] [Related]
18. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis.
Katugampola RP; Lewis VJ; Finlay AY
Br J Dermatol; 2007 May; 156(5):945-50. PubMed ID: 17388922
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease.
Reguiaï Z; Grange F
Am J Clin Dermatol; 2007; 8(2):67-77. PubMed ID: 17428111
[TBL] [Abstract][Full Text] [Related]
20. Biological therapy for psoriasis.
Clements SE; Abdul-Ghaffar S; Griffiths CE
Br J Hosp Med (Lond); 2006 Apr; 67(4):184-7. PubMed ID: 16681304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
